We are live on ! Find out more
CALC icon

CalciMedica

24 hedge funds and large institutions have $13.6M invested in CalciMedica in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

100% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 3

15% more capital invested

Capital invested by funds: $11.8M → $13.6M (+$1.78M)

14% more funds holding

Funds holding: 2124 (+3)

0.82% more ownership

Funds ownership: 27.67%28.49% (+0.82%)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
24
Holders Change
+3
Holders Change %
+14.29%
% of All Funds
0.34%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
5
Increased
6
Reduced
3
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Qube Research & Technologies (QRT)
26
Qube Research & Technologies (QRT)
United Kingdom
-$4 -1 Closed

CALC Hedge Fund Activity: Q3 2024 in Review

24 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in CalciMedica (CALC) for Q3 2024, worth a combined $13.6M — up 15% from $11.8M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new CALC positions and 2 closed out — a net gain of 3 holders — while 6 added to existing stakes and 3 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $99K. The largest seller was BML Capital Management, cutting an estimated $28.7K.

  • 24 institutional investors held CalciMedica (CALC) as of Q3 2024, up from 21 in Q2 2024.
  • Funds reported $13.6M of CalciMedica stock for Q3 2024, up 15% quarter-over-quarter.
  • 5 funds opened new CalciMedica positions in Q3 2024 and 2 closed out, a net change of +3 holders.
  • The largest CalciMedica buyer in Q3 2024 was Geode Capital Management, an estimated $99K added.
  • The largest CalciMedica seller in Q3 2024 was BML Capital Management, an estimated $28.7K sold.

Based on aggregated 13F filings for Q3 2024.